Early reduction in standardized uptake value after one cycle of neoadjuvant chemotherapy measured by sequential FDG PET/CT is an independent predictor of pathological response of primary breast cancer

Breast Journal

Volumn 16, Issue 6, 2010, Pages 660-662

  Ueda, Shigeto ^a   Tsuda, Hitoshi ^a   Saeki, Toshiaki ^b,c   Osaki, Akihiko ^b,c   Shigekawa, Takashi ^b,c   Ishida, Jiro ^d   Tamura, Katsumi ^d   Abe, Yoshiyuki ^d   Omata, Jiro ^a   Moriya, Tomoyuki ^a   Fukatsu, Kazuhiko ^a   Yamamoto, Junji ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Tokorozawa Ichou Hospital   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d Tokorozawa PET Diagnostic Imaging Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUORODEOXYGLUCOSE F 18; PACLITAXEL;

ADULT; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; LETTER; METABOLIC PARAMETERS; MULTIPLE CYCLE TREATMENT; PRIMARY TUMOR; TREATMENT RESPONSE; ULTRASOUND;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78449266350     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2010.01011.x     Document Type: Letter

References (5)

1. Juweid ME, Cheson BD,. Positron-emission tomography and assessment of cancer therapy. N Engl J Med 2006; 354: 496-507.
2. Schelling M, Avril N, Nahrig J, et al. Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol 2000; 18: 1689-95.
3. Rousseau C, Devillers A, Sagan C, et al. Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F] fluorodeoxyglucose positron emission tomography. J Clin Oncol 2006; 24: 5366-72.
4. Ueda S, Tsuda H, Asakawa H, et al. Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer. Jpn J Clin Oncol 2008; 38: 250-8.
5. Sakamoto G, Inaji H, Akiyama F, et al. General rules for clinical and pathological recording of breast cancer 2008. Breast Cancer 2008; 12 (Suppl): S1-27.